fashion -WSS

fashion

author：fashion 2025-10-01 23:02:04 - browse：5346

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare drug price negotiation program allowed for now

hotspot

focus

WSS

Ionis has late

Biogen shutters digital health group, ends Apple study, in cost cutting move

Why the quest to eradicate polio has stumbled

How the messy conversation about Dolly changed bioethics

How the Dana

David Liu startup to focus on CRISPR delivery

focus

fashion

explore

23andMe had bad news about my health. I wish a person had delivered it

Listen: Who gets the credit for GLP

How to save PrEP access — and even expand it

Fed up with FDA, ALS advocates consider a take

Affirmative action in medical school literally saved lives

Information blocking fines are now fair game in health care

Duchenne breakthrough therapy leaves behind pioneering families

Kaiser Permanente unions announce official strike date

BioMarin wins approval for gene therapy to treat hemophilia A

Midwives could help bridge maternal health disparities in the U.S.

explore

People with substance use disorder deserve online privacy

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Covid’s new normal has set in amid another rise in cases

Sudafed saga points to U.S. issues with evaluating older drugs

Assistant physicians can help address the primary care shortage

After a drawn out lobbying fight, ARPA

hotspot

focus

explore

focus